Ftse Mib
34.718,18
0,65%
DAX
18.629,13
0,79%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
0,00%
Bitcoin
69.148,02
2,07%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BioMarin Pharmaceutical Inc (BMRN) BioMarin Pharmaceutical Inc (BMRN) Notizie

BioMarin Pharmaceutical Inc

BMRN
74,55
-0,52 (-0,69%)
Pre Mercato
Ultimo aggiornamento: 13:50:58
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/6/202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202416:49EDGAR2Form 144 - Report of proposed sale of securities
31/5/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202420:22EDGAR2Form 144 - Report of proposed sale of securities
30/5/202416:18EDGAR2Form 144 - Report of proposed sale of securities
30/5/202416:10EDGAR2Form 144 - Report of proposed sale of securities
29/5/202416:28EDGAR2Form 144 - Report of proposed sale of securities
28/5/202416:36EDGAR2Form 144 - Report of proposed sale of securities
24/5/202422:02EDGAR2Form 8-K - Current report
23/5/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/5/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202423:16EDGAR2Form 8-K - Current report
13/5/202421:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202416:11EDGAR2Form 144 - Report of proposed sale of securities
09/5/202416:54EDGAR2Form 144 - Report of proposed sale of securities
08/5/202414:00PRNUSBioMarin to Present at the BofA Securities 2024 Health Care..
07/5/202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/5/202422:00PRNUSNew Data for BioMarin's VOXZOGO® (vosoritide) for Multiple..
24/4/202422:03PRNUSBioMarin Reports Record Financial Results for the First..
10/4/202414:00PRNUSBioMarin to Host First Quarter 2024 Financial Results..
12/3/202413:30PRNUSNew Data to be Presented for BioMarin's VOXZOGO®..
08/3/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202414:30PRNUSBioMarin Announces Appointment of Cristin Hubbard as Chief..
06/3/202418:04EDGAR2Form 144 - Report of proposed sale of securities
05/3/202422:17EDGAR2Form 144 - Report of proposed sale of securities
05/3/202420:41EDGAR2Form 144 - Report of proposed sale of securities
05/3/202418:04EDGAR2Form 144 - Report of proposed sale of securities
01/3/202415:00PRNUSBioMarin Scheduled to Participate in March Investor..
29/2/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 75,07

La tua Cronologia

NASDAQ
BMRN
BioMarin Pharmaceutical
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network